Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02205359
Other study ID # AdaptResponse
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date November 2, 2022

Study information

Verified date November 2023
Source Medtronic Cardiac Rhythm and Heart Failure
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this clinical study is to test the hypothesis that market released Cardiac Resynchronization Therapy (CRT) devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal atrio-ventricular (AV) conduction and left bundle branch block (LBBB).


Recruitment information / eligibility

Status Completed
Enrollment 3797
Est. completion date November 2, 2022
Est. primary completion date November 2, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject is willing to sign and date the study Patient Informed Consent Form. - Subject is indicated for a CRT device according to local guidelines. - Sinus Rhythm at time of enrollment - Complete Left Bundle Branch Block (LBBB) as documented on an ECG (within 30 days prior to enrollment). Strauss Criteria used for LBBB. - Intrinsic, normal AV conduction as documented on an ECG by a PR interval less than or equal to 200ms (within 30 days prior to enrollment). - Left ventricular ejection fraction less than or equal to 35% (documented within 180 days prior to enrollment). - NYHA class II, III or IV (documented within 30 days prior to enrollment) despite optimal medical therapy. Optimal medical therapy is defined as maximal tolerated dose of Beta-blockers and a therapeutic dose of ACE-I, ARB or Aldosterone Antagonist. Exclusion Criteria: - Subject is less than 18 years of age (or has not reached minimum age per local law). - Subject is not expected to remain available for at least 2 years of follow-up visits. - Subject has permanent atrial arrhythmias for which pharmacological therapy and/or cardioversion have been unsuccessful or have not been attempted - Subject is, or previously has been, receiving cardiac resynchronization therapy. - Subject is currently enrolled or planning to participate in a potentially confounding drug or device trial during the course of this study. Co-enrollment in concurrent trials is only allowed when documented pre-approval is obtained from the Medtronic study manager. - Subject has unstable angina, or experienced an acute myocardial infarction (MI) or received coronary artery revascularization (CABG) or coronary angioplasty (PTCA) within 30 days prior to enrollment. - Subject has a mechanical tricuspid heart valve or is scheduled to undergo valve repair or valve replacement during the course of the study. - Subject is post heart transplant (subjects on the heart transplant list for the first time are not excluded). - Subject has a limited life expectancy due to non-cardiac causes that would not allow completion of the study. - Subject is pregnant (if required by local law, women of child-bearing potential must undergo a pregnancy test within seven days prior to device implant). - Subject meets any exclusion criteria required by local law.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
aCRT ON
CRT device with AdaptivCRT enabled (AdaptivBiV and LV)
aCRT OFF
CRT device with AdaptivCRT disabled

Locations

Country Name City State
Australia Austin Hospital Heidelberg Victoria
Australia Fiona Stanley Hospital Murdoch Western Australia
Australia John Hunter Hospital New Lambton New South Wales
Australia Saint Vincent's Hospital (Sydney) Sydney
Austria Landeskrankenhaus Innsbruck - Universitätskliniken Innsbruck
Austria Allgemeines Krankenhaus der Stadt Linz Linz
Belgium AZ Sint-Jan Brugge-Oostende av Brugge
Belgium Ziekenhuis Oost Limburg - Campus St.-Jan Genk
Canada London Health Sciences Centre - University Campus London
Canada McGill Universtiy Health Centre (MUHC) Montreal
Canada Southlake Regional Health Centre Newmarket
Canada University of Ottawa Heart Institute Ottawa
Canada Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Quebec
Canada Royal Columbian Hospital Vancouver
Canada Vancouver General Hospital Vancouver
Denmark Odense Universitetshospital Odense C
Finland Keski-Suomen Keskussairaala Jyväskylä
Finland Satakunnan keskussairaala Pori
France Centre Hospitalier Universitaire de Amiens - Hôpital SU Amiens
France CHRU Tours - Hôpital Trousseau Chambray lès tours
France Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied Clermont-Ferrand
France Centre Hospitalier Sud Francilien Corbeil-Essonnes
France CHRU La Rochelle La Rochelle
France Centre Hospitalier Universitaire de Grenoble-Hopital Albert Michallon La Tronche
France CHRU de Lille Lille
France groupe Hospitalier de L'Institut Catholique de Lille - Hôpital Saint-Philibert Lomme
France Hôpital de la Timone - Centre Hospitalier Universitaire de Marseille Marseille
France Hopital prive Clairval - Ramsay Sante Marseille
France Institut Hospitalier Jacques Cartier Massy
France CHR Metz-Thionville Hôpital de Mercy Metz
France CHRU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier Cedex 5
France Nouvelles Cliniques Nantaises Nantes
France CMC-Clinique Ambroise Pare Neuilly-sur-Seine
France Hôpital Pontchaillou - CHU de Rennes Rennes Cedex 9
France CHU Toulouse - Hôpital Rangueil Toulouse Cedex 9
Germany Immanuel Diakonie Group - Evangelisch-Freikirchlichen Krankenhaus und Herzzentrum Brandenburg Bernau bei Berlin
Germany Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum Bochum
Germany MVZ am Küchwald GmbH ambulantes Herz Zentrum Chemnitz Chemnitz
Germany Klinikum Coburg GmbH Coburg
Germany Praxisklinik Herz und Gefässe - Akademische Lehrpraxisklinik der TU Dresden Dresden
Germany Universitätsklinikum Düsseldorf Düsseldorf
Germany Universitätsklinikum Heidelberg Heidelberg
Germany Universitätskliniken des Saarlandes Homburg/Saar
Germany Universitätsklinikum Jena - Friedrich Schiller Universität Jena
Germany Universitätsklinikum Schleswig-Holstein - Campus Lübeck Lübeck
Germany Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH Lüdenscheid
Germany Märkische Gesundheitsholding GmbH & Co. KG - Klinikum Lüdenscheid Lüdenscheid
Germany Otto von Guericke Universität - Universitätsklinikum Magdeburg A.ö.R. Magdeburg
Germany Kliniken Maria Hilf GmbH Mönchengladbach - Krankenhaus St. Franziskus Mönchengladbach
Germany Klinikum der Universität München - Campus Großhadern München
Germany Herz Riesa, Gemeinschaftspraxis Riesa
Germany Universitätsklinikum Ulm Ulm
Hungary Magyar Honvédség Honvédkorház Budapest
Hungary Semmelweis Egyetem AOK Budapest
India Medanta - The Medicity Gurgaon
India Fortis Escorts Heart Institute New Delhi
Italy Policlinico Sant' Orsola - Malpighi Bologna
Italy Azienda Ospedaliera Spedali Civili di Brescia Brescia
Italy Ospedale Civile Madonna Della Navicella Chioggia
Italy Azienda Ospedaliera Carlo Poma Mantova
Italy Azienda Ospedaliero-Universitaria di Parma Parma
Italy Azienda Ospedaliera Universitaria Integrata Verona Verona
Japan Chiba University Hospital Chiba-Shi
Japan Hirosaki University Hospital Hirosaki Aomori Prefecture
Japan Kokura Memorial Hospital Kitakyushu
Japan Kyorin University Hospital Mitaka-Shi
Japan Nagoya University Hospital Nagoya
Japan Sakakibara Heart Institute of Okayama Okayama-Shi
Japan Saitama Medical Center Jichi Medical University Shimonoseki-Shi
Japan National Cerebral and Cardiovascular Center Suita-Shi
Japan Fujita Health University Hospital Toyoake
Japan University of Fukui Hospital Tsukuba
Korea, Republic of Keimyung University Dongsan Medical Center Daegu
Korea, Republic of Yeungnam University Medical Center Daegu
Korea, Republic of Seoul National University Bundang Hospital Gyeonggi-Do
Korea, Republic of Kyung Hee University Hospital Seoul
Korea, Republic of Samsung Medical Center Seoul
Korea, Republic of Seoul National University Hospital Seoul
Mexico Hospital Angeles Leon Leon Guanajuato
Netherlands Academisch Medisch Centrum Amsterdam
Netherlands Amphia Ziekenhuis - Locatie Molengracht Breda Breda
Netherlands Medisch Centrum Leeuwarden Leeuwarden
Netherlands Canisius-Wilhelmina ziekenhuis Nijmegen
Netherlands Erasmus Medisch Centrum Rotterdam
Netherlands Maasstad Ziekenhuis Rotterdam
Netherlands Universitair Medisch Centrum Utrecht Utrecht
Netherlands Isala Klinieken - Locatie Weezenlanden Zwolle
Norway Helse Bergen HF - Haukeland Universitetssjukehus Bergen
Poland Wojewódzki Szpital Zespolony im. Ludwika Perzyny w Kaliszu Kalisz
Poland Górnoslaskie Centrum Medyczne im prof Leszka Gieca Slaskiego Uniwersytetu Medycznego w Katowicach Katowice
Poland Regional Hospital Szpital Wojewodski Kielce
Poland Wojewódzki Szpital Specjalistyczny im. Stefana Kardynala Wyszynskiego Lublin
Poland Spital Wojewodzki nr 2 Rzeszów
Poland Slaskie Centrum Chorob Serca Zabrze
Portugal Unidade Local de Saude do Baixo Alentejo, EPE - Hospital José Joaquim Fernandes Beja
Portugal Centro Hospitalar de Coimbra Coimbra
Portugal Hospital de Espírito Santo E.P.E. Évora
Puerto Rico The Arrhythmia Group Coto Laurel
Puerto Rico Cardiovascular Center San Juan
Russian Federation AV Vishnevsky Institute of Surgery of the Ministry of Health of the Russian Federation Moscow
Russian Federation EN Meshalkin National medical research center of the Ministry of Health of the Russian Federation Novosibirsk
Russian Federation Almazov National Medical Research Centre St Petersburg
Saudi Arabia King Abdul Aziz University Hospital Jeddah
Saudi Arabia King Fahad Armed Forces Hospital Jeddah
Saudi Arabia King Faisal Specialist Hospital & Research Center Riyadh
Saudi Arabia The College of Medicine & King Khalid University Hospital, King Saud University Riyadh
Slovakia Stredoslovensky ustav srdcovych a cievnych chorob a.s Banska Bystrica
Slovakia NUSCH, a.s. Bratislava 37
Spain Hospital Universitario Infanta Cristina Badajoz
Spain Nuevo Hospital de Burgos Burgos
Spain Hospital Virgen de la Arrixaca El Palmar
Spain Hospital Universitario Virgen de las Nieves Granada
Spain Hospital Clínico Virgen de la Victoria Málaga
Spain Hospital Clinico Universitario de Salamanca Salamanca
Spain Hospital Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife
Spain Hospital Universitario Virgen del Rocío Sevilla
Spain Complexo Hospitalario Universitario de Vigo - Hospital Xeral Cíes Vigo
Spain Hospital Universitario Miguel Servet Zaragoza
Sweden Karolinska Universitetssjukhuset Solna
Sweden Akademiska Sjukhuset Uppsala
Switzerland Universitätsspital Basel Basel
Switzerland HFR Fribourg - Hôpital cantonal Fribourg
Switzerland Kantonsspital St.Gallen Saint Gallen
Taiwan National Taiwan University Hospital Hsin Chu Branch Hsinchu
Taiwan National Taiwan University Hospital Taipei
United Kingdom Golden Jubilee National Hospital - NHS Trust Glasgow
United Kingdom Liverpool Heart and Chest Hospital NHS Foundation Trust Liverpool
United Kingdom University Hospitals of North Midlands NHS Trust - Royal Stoke University Hospital Liverpool
United Kingdom Royal Brompton & Harefield NHS Foundation Trust - Royal Brompton Hospital London
United Kingdom Manchester University NHS Foundation Trust - Wythenshawe Hospital Manchester
United States Presbyterian Heart Group Albuquerque New Mexico
United States Lehigh Valley Hospital Allentown Pennsylvania
United States University of Michigan Ann Arbor Michigan
United States Asheville Cardiology Associate PA Asheville North Carolina
United States Emory University Hospital Midtown Atlanta Georgia
United States Piedmont Heart Institute Atlanta Georgia
United States Texas Cardiac Arrhythmia Research Austin Texas
United States MedStar Health Research Institute Baltimore Maryland
United States Massachusetts General Hospital (Boston MA) Boston Massachusetts
United States Bridgeport Hospital Bridgeport Connecticut
United States New York Methodist Hospital Brooklyn New York
United States The University of Vermont Medical Center Inc Burlington Vermont
United States Capital Area Research Camp Hill Pennsylvania
United States CAMC Health Education & Research Institute Inc Charleston West Virginia
United States Medical University of South Carolina (MUSC) Charleston South Carolina
United States University of Virginia Medical Center Charlottesville Virginia
United States Northwerstern University Chicago Illinois
United States Bethesda North Hospital Cincinnati Ohio
United States The Lindner Research Center Cincinnati Ohio
United States Heart & Vascular Institute of Florida Clearwater Florida
United States Cleveland Clinic Cleveland Ohio
United States University Hospitals Case Medical Center Cleveland Ohio
United States Penrose Hospital Colorado Springs Colorado
United States Mount Carmel East Columbus Ohio
United States OhioHealth Research Institute Columbus Ohio
United States The Ohio State University Columbus Ohio
United States The University of Texas (UT) Southwestern Medical Center Dallas Texas
United States Duke University Medical Center (DUMC) Durham North Carolina
United States North Ohio Heart-Elyria Elyria Ohio
United States Sacred Heart Medical Center Eugene Oregon
United States Florida Heart Rhythm Specialists PLLC Fort Lauderdale Florida
United States The Cardiac & Vascular Institute Gainesville Florida
United States Wake Forest Baptist Health High Point Medical Center High Point North Carolina
United States CHI St. Luke's Heath Baylor College of Medicine Medical Center Houston Texas
United States Saint Francis Medical Group Indiana Heart Physician Indianapolis Indiana
United States First Coast Cardiovascular Institute PA Jacksonville Florida
United States Glacier View Research Institute Cardiology Kalispell Montana
United States Mid America Heart Institute (MAHI) Kansas City Missouri
United States Scripps Green Hospital Scripps Clinic Torrey Pines La Jolla California
United States Lancaster General Hospital Lancaster Pennsylvania
United States Sparrow Clinical Research Institute Lansing Michigan
United States Saint Vincent Heart Clinic Arkansas Little Rock Arkansas
United States Cedars-Sinai Medical Center Los Angeles California
United States Medical Center of the Rockies Loveland Colorado
United States Sutherland Cardiology Clinic Memphis Tennessee
United States CardioVascular Associates of Mesa Mesa Arizona
United States Cardiovascular Research Center of South Florida Miami Florida
United States Aurora Cardiovascular Services Milwaukee Wisconsin
United States Medical College of Wisconsin Milwaukee Wisconsin
United States University of Minnesota Medical Center Fairview Minneapolis Minnesota
United States Centennial Heart Cardiovascular Consultants LLC Nashville Tennessee
United States Vanderbilt University Medical Center Nashville Tennessee
United States Ochsner Medical Center New Orleans Louisiana
United States Icahn School of Medicine at Mount Sinai New York New York
United States NYU Langone Medical Center New York New York
United States Weill Medical College of Cornell University New York New York
United States Mercer Bucks Cardiology Newtown Pennsylvania
United States Sentara Norfolk General Hospital Norfolk Virginia
United States Oklahoma Heart Hospital Research Foundation Oklahoma City Oklahoma
United States AdventHealth Cardiovascular Research Institute Orlando Florida
United States Cardiology Institute of Northwest Florida Panama City Florida
United States Thomas Jefferson University Hospital Philadelphia Pennsylvania
United States University of Pennsylvania Philadelphia Pennsylvania
United States Phoenix Cardiovascular Research Group, LLC Phoenix Arizona
United States University of Pittsburgh Medical Center UPMC Presbyterian Pittsburgh Pennsylvania
United States Baylor Research Institute Plano Texas
United States Hudson Valley Heart Center Poughkeepsie New York
United States Raleigh Cardiology Associates Raleigh North Carolina
United States Virginia Cardiovascular Specialists PC Richmond Virginia
United States Virginia Commonwealth University Health System Richmond Virginia
United States North Memorial Heart and Vascular Institute Robbinsdale Minnesota
United States Washington University School of Medicine Saint Louis Missouri
United States United Heart and Vascular Clinic Saint Paul Minnesota
United States University of Utah Salt Lake City Utah
United States Coggins & Levy Medical Associates San Jose California
United States Great Valley Cardiology Scranton Pennsylvania
United States Swedish Medical Center Cherry Hill Seattle Washington
United States Providence Spokane Cardiology Spokane Washington
United States Prairie Education and Research Cooperative Springfield Illinois
United States Stanford Hospital & Clinics Stanford California
United States Saint Joseph's Medical Center Stockton California
United States Stony Brook University Medical Center Stony Brook New York
United States University of South Florida Health (USF) Tampa Florida
United States EP Heart LLC The Woodlands Texas
United States William Beaumont Hospital Troy Michigan
United States Tyler Cardiovascular Consultants Tyler Texas
United States Central New York Cardiology Utica New York
United States Lourdes Cardiology Services Voorhees New Jersey
United States Washington Hospital Center Washington District of Columbia
United States Michigan Heart Ypsilanti Michigan

Sponsors (1)

Lead Sponsor Collaborator
Medtronic Cardiac Rhythm and Heart Failure

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Belgium,  Canada,  Denmark,  Finland,  France,  Germany,  Hungary,  India,  Italy,  Japan,  Korea, Republic of,  Mexico,  Netherlands,  Norway,  Poland,  Portugal,  Puerto Rico,  Russian Federation,  Saudi Arabia,  Slovakia,  Spain,  Sweden,  Switzerland,  Taiwan,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Combined Endpoint of All-cause Mortality and Intervention for Heart Failure Decompensation The first occurrence of death or intervention for heart failure decompensation (defined as an event requiring invasive intervention or inpatient hospitalization). from subject randomization until the first occurrence of death or intervention for heart failure decompensation, median follow-up 4.9 years (max. follow-up 8.1 years)
Secondary All-cause Mortality All-cause mortality in the aCRT ON group vs the aCRT OFF group from subject randomization until the occurrence of death, median follow-up 4.9 years (max. follow-up 8.1 years)
Secondary Percent of Patients With Interventions for Heart Failure Decompensation First occurence of intervention for heart failure decompensation is defined as an event requiring invasive intervention or inpatient hospitalization. from subject randomization until the first occurrence of intervention for heart failure decompensation, median follow-up 4.9 years (max. follow-up 8.1 years)
Secondary Clinical Composite Score The Clinical Composite Score (CCS) classifies patients according their clinical status at 6 months post randomization into categories Improved, Unchanged, and Worsened. A patient is classified Worsened in case of death, hospitalization for worsening heart failure, worsened NYHA class (using last observation carried forward), or worsened status on the Global Assessment Score. Also patients that exit the study or cross over because of worsening heart failure are classified Worsened. A patient is classified Improved when not Worsened and there is an improvement in NYHA class or Global Assessment Score. Patients that are not Worsened or Improved are Unchanged. CCS at 6 month post randomization
Secondary Atrial Fibrillation Occurrence of atrial fibrillation lasting >6 hours in one day from subject randomization until the first occurrence of atrial fibrillation lasting >6 hours in one day, median follow-up 4.9 years (max. follow-up 8.1 years)
Secondary Change in Quality of Life Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) The overall summary score of the Kansas City Cardiomyopathy Questionnaire will be analyzed. The KCCQ measures Quality of Life on a 0-100 scale with higher scores indicating better QoL from baseline to 24M follow up
Secondary Change in Quality of Life Measured by the EQ-5D The EQ-5D descriptive system comprises the following five dimensions, each describing a different aspect of health: MOBILITY, SELF-CARE, USUAL ACTIVITIES, PAIN /DISCOMFORT and ANXIETY / DEPRESSION. Each dimension has three levels: no problems, some problems, extreme problems (labelled 1-3). We calculated the EQ-5D summary index by applying a specific formula providing a valuation to the health states (Shaw et al. Medical Care 2005). For the summary index, value 0 represents health that is valued as equal to death and value 1 represents best possible health. from baseline to 24M follow up
Secondary All-cause Re-admissions Within 30 Days After a Heart Failure Admission Per 100 Patient Years All-cause hospital re-admissions within 30 days after discharge from a heart failure admission are reported as number of cases per 100 patient years from subject randomization until study exit, median follow-up 4.9 years (max. follow-up 8.1 years)